Shingles Vaccine Slashes Cardiac Risk by Nearly 50% for Adults with Established Heart Disease

New research from ACC.26 shows the shingles vaccine reduces major cardiac events by 46% in patients with heart disease, rivaling the benefits of quitting smoking.

By: AXL Media

Published: Mar 17, 2026, 8:58 AM EDT

Source: Information for this report was sourced from American College of Cardiology

A New Frontier in Cardioprotective Medicine

The medical community has long recognized the shingles vaccine as a vital tool for preventing painful skin rashes and long-term nerve pain, but new research suggests its benefits extend deep into the cardiovascular system. A study analyzed over 246,000 adults with atherosclerotic heart disease—a condition characterized by dangerous plaque buildup in the arteries—to determine if the vaccine influenced cardiac outcomes. Lead author Dr. Robert Nguyen of the University of California, Riverside, reported that the findings add to a growing body of evidence showing that the vaccine significantly reduces the risk of heart attack, stroke, and overall mortality. For those already living with heart disease, the protective effects appear to be even more pronounced than in the general population.

The Biological Link Between Virus and Vasculature

The protection offered by the shingles vaccine is likely rooted in the prevention of herpes zoster reactivation. When the dormant chickenpox virus reactivates as shingles, it can trigger systemic inflammation and the formation of blood clots around the brain and heart. These clots are the primary drivers of venous thromboembolism, strokes, and heart attacks. By keeping the virus in a dormant state, the vaccine effectively removes a major biological trigger for these life-threatening events. The study suggests that for high-risk patients, the vaccine acts as a secondary shield for the heart, preventing the viral "storm" that often precedes a cardiac crisis.

Staggering Reductions in Mortality and Stroke

The statistical results of the study, which utilized the massive TriNetX health record database, were remarkably high. Vaccinated individuals were 66% less likely to die from any cause during the one-year follow-up period compared to their unvaccinated peers. Furthermore, the risk of a heart attack dropped by 32%, while the risk of stroke and heart failure both decreased by 25%. Dr. Nguyen noted that these levels of risk reduction are substantial, comparable to the health benefits achieved by quitting smoking. These findings provide a powerful clinical argument for the CDC’s recommendation that all adults over the age of 50 receive the vaccine, regardless of their current heart health.